Short Interest in Surgical Science Sweden AB (publ) (OTCMKTS:SUSRF) Expands By 135.9%

Surgical Science Sweden AB (publ) (OTCMKTS:SUSRF) was the target of a significant increase in short interest during the month of May. As of May 31st, there was short interest totalling 135,400 shares, an increase of 135.9% from the May 15th total of 57,400 shares. Based on an average daily trading volume, of 2,400 shares, the short-interest ratio is currently 56.4 days.

Surgical Science Sweden AB (publ) Stock Performance

Shares of SUSRF opened at $16.33 on Friday. Surgical Science Sweden AB has a 1-year low of $11.30 and a 1-year high of $16.33. The company’s fifty day simple moving average is $13.50 and its 200 day simple moving average is $13.74.

About Surgical Science Sweden AB (publ)

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexVR, a flexible and portable training platform which is designed to teach basic and advanced skills for robotic surgery; and LAP Mentor provides a wide array of laparoscopic training cases.